PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
INO vs. MDU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INO and MDU is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

INO vs. MDU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-80.38%
27.04%
INO
MDU

Key characteristics

Sharpe Ratio

INO:

-0.84

MDU:

3.31

Sortino Ratio

INO:

-1.46

MDU:

4.24

Omega Ratio

INO:

0.82

MDU:

1.55

Calmar Ratio

INO:

-0.75

MDU:

5.71

Martin Ratio

INO:

-1.58

MDU:

17.42

Ulcer Index

INO:

47.32%

MDU:

4.74%

Daily Std Dev

INO:

88.58%

MDU:

24.96%

Max Drawdown

INO:

-99.92%

MDU:

-61.78%

Current Drawdown

INO:

-99.90%

MDU:

-7.05%

Fundamentals

Market Cap

INO:

$79.42M

MDU:

$3.79B

EPS

INO:

-$4.43

MDU:

$1.94

PEG Ratio

INO:

0.00

MDU:

1.67

Total Revenue (TTM)

INO:

$100.76K

MDU:

$3.31B

Gross Profit (TTM)

INO:

-$1.49M

MDU:

$514.60M

EBITDA (TTM)

INO:

-$85.34M

MDU:

$526.58M

Returns By Period

In the year-to-date period, INO achieves a 20.22% return, which is significantly higher than MDU's 3.27% return. Over the past 10 years, INO has underperformed MDU with an annualized return of -32.01%, while MDU has yielded a comparatively higher 12.53% annualized return.


INO

YTD

20.22%

1M

19.57%

6M

-80.32%

1Y

-73.50%

5Y*

-45.71%

10Y*

-32.01%

MDU

YTD

3.27%

1M

2.82%

6M

27.04%

1Y

80.46%

5Y*

15.09%

10Y*

12.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INO vs. MDU — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INO
The Risk-Adjusted Performance Rank of INO is 55
Overall Rank
The Sharpe Ratio Rank of INO is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of INO is 55
Sortino Ratio Rank
The Omega Ratio Rank of INO is 66
Omega Ratio Rank
The Calmar Ratio Rank of INO is 66
Calmar Ratio Rank
The Martin Ratio Rank of INO is 44
Martin Ratio Rank

MDU
The Risk-Adjusted Performance Rank of MDU is 9797
Overall Rank
The Sharpe Ratio Rank of MDU is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of MDU is 9797
Sortino Ratio Rank
The Omega Ratio Rank of MDU is 9696
Omega Ratio Rank
The Calmar Ratio Rank of MDU is 9898
Calmar Ratio Rank
The Martin Ratio Rank of MDU is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INO vs. MDU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for INO, currently valued at -0.84, compared to the broader market-2.000.002.004.00-0.843.31
The chart of Sortino ratio for INO, currently valued at -1.46, compared to the broader market-4.00-2.000.002.004.006.00-1.464.24
The chart of Omega ratio for INO, currently valued at 0.82, compared to the broader market0.501.001.502.000.821.55
The chart of Calmar ratio for INO, currently valued at -0.75, compared to the broader market0.002.004.006.00-0.755.71
The chart of Martin ratio for INO, currently valued at -1.58, compared to the broader market0.0010.0020.0030.00-1.5817.42
INO
MDU

The current INO Sharpe Ratio is -0.84, which is lower than the MDU Sharpe Ratio of 3.31. The chart below compares the historical Sharpe Ratios of INO and MDU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.84
3.31
INO
MDU

Dividends

INO vs. MDU - Dividend Comparison

INO has not paid dividends to shareholders, while MDU's dividend yield for the trailing twelve months is around 2.44%.


TTM20242023202220212020201920182017201620152014
INO
Inovio Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.28%0.00%0.00%0.00%
MDU
MDU Resources Group, Inc.
2.44%2.52%5.20%4.63%4.46%3.83%4.40%3.35%5.22%3.17%5.63%4.90%

Drawdowns

INO vs. MDU - Drawdown Comparison

The maximum INO drawdown since its inception was -99.92%, which is greater than MDU's maximum drawdown of -61.78%. Use the drawdown chart below to compare losses from any high point for INO and MDU. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-99.90%
-7.05%
INO
MDU

Volatility

INO vs. MDU - Volatility Comparison

Inovio Pharmaceuticals, Inc. (INO) has a higher volatility of 27.46% compared to MDU Resources Group, Inc. (MDU) at 7.45%. This indicates that INO's price experiences larger fluctuations and is considered to be riskier than MDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember2025
27.46%
7.45%
INO
MDU

Financials

INO vs. MDU - Financials Comparison

This section allows you to compare key financial metrics between Inovio Pharmaceuticals, Inc. and MDU Resources Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab